BRD4 and nevus comedonicus syndrome: Our findings align with previous research that implicates the NUTM1 fusion gene as the key driver of NC oncogenesis, as evidenced by the induction of NC in vivo through activation of the BRD4::NUTM1 fusion gene and growth arrest following fusion protein knockdown or degradation.2